Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Mar 1;22(3):e168-e177.
doi: 10.1097/PCC.0000000000002578.

Outcome of Early Hemostatic Intervention in Children With Sepsis and Nonovert Disseminated Intravascular Coagulation Admitted to PICU: A Randomized Controlled Trial

Ahmed A El-Nawawy  1 , Mohamed I Elshinawy  1 , Doaa M Khater  1   2 , Azza A Moustafa  1   2 , Nehad M Hassanein  1 , Yasser A Wali  1   2 , Hanan F Nazir  1   2
Affiliations
Randomized Controlled Trial

Outcome of Early Hemostatic Intervention in Children With Sepsis and Nonovert Disseminated Intravascular Coagulation Admitted to PICU: A Randomized Controlled Trial

Ahmed A El-Nawawy et al. Pediatr Crit Care Med. .

Abstract

Objectives: Evaluation of the outcome of early hemostatic management of disseminated intravascular coagulopathy in patients with severe sepsis/septic shock admitted to PICU, before the development of clinically overt disseminated intravascular coagulopathy.

Design: Prospective interventional, open label randomized controlled clinical trial.

Setting: PICU at Alexandria University Children's Hospital.

Patients: The study included 80 patients with proven severe sepsis/septic shock in nonovert disseminated intravascular coagulopathy stage. They were randomly assigned into two groups (group 1 and group 2).

Interventions: Specific intervention was applied for group 1 (plasma transfusion, low-dose unfractionated heparin, and tranexamic acid).

Measurements: All patients had assessment of Pediatric Index of Mortality 2 score, Pediatric Logistic Organ Dysfunction score, inotropic score, routine laboratory, and hemostatic tests including fibrin degradation products and d-dimers. Disseminated intravascular coagulopathy risk assessment scores were calculated on daily basis.

Results: Mortality rate was significantly higher in group 2. Progression to overt disseminated intravascular coagulopathy was significantly more common among group 2 patients than group 1 (45% and 10%, respectively) (p < 0.0001). Disseminated intravascular coagulopathyRisk Assessment Scores were significantly higher on the second and fifth days among group 2 patients. The initial specific hemostatic intervention was the only significant predictor of survival and prevention of progression to overt disseminated intravascular coagulopathy.

Conclusions: Our results suggest that early use of a combination of fresh frozen plasma transfusion, low-dose heparin, and tranexamic acid in children with severe sepsis/septic shock in the "window of opportunity" before the development of overt disseminated intravascular coagulopathy stage was associated with better outcome for survival and prevention of progression to overt disseminated intravascular coagulopathy, with no increase in bleeding risk. Larger multicenter studies are needed to further prove this practice.

PubMed Disclaimer

Conflict of interest statement

The authors have disclosed that they do not have any potential conflicts of interest.

Comment in

References

    1. Carey MJ, Rodgers GM: Disseminated intravascular coagulation: Clinical and laboratory aspects. Am J Hematol. 1998; 59:65–73
    1. Levi M: Current understanding of disseminated intravascular coagulation. Br J Haematol. 2004; 124:567–576
    1. Levi M, de Jonge E, van der Poll T: Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis. 2003; 16:43–47
    1. Esmon CT, Fukudome K, Mather T, et al.: Inflammation, sepsis, and coagulation. Haematologica. 1999; 84:254–259
    1. Bick RL, Arun B, Frenkel EP: Disseminated intravascular coagulation. Clinical and pathophysiological mechanisms and manifestations. Haemostasis. 1999; 29:111–134

Publication types

LinkOut - more resources